Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Class A
Common Class B
Common Class C
Common stock
Common Class A
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 28, 2017           95,509,000        
Beginning balance at Dec. 28, 2017 $ 442,860 $ 7,826       $ 96 $ 323,419 $ (205) $ 119,550 $ 7,826
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense 6,514           6,514      
Exercise of stock options (in shares)           2,069,000        
Exercise of stock options 10,531         $ 2 10,529      
Issuance of restricted stock award (in shares)           10,000        
Other comprehensive income gain (loss), net of tax 391             391    
Net income 116,187               116,187  
Ending balance (in shares) at Dec. 27, 2018           97,588,000        
Ending balance at Dec. 27, 2018 $ 584,309 $ (179)       $ 98 340,462 186 243,563 $ (179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member                  
Stock-based compensation expense $ 8,711           8,711      
Exercise of stock options (in shares)           3,741,000        
Exercise of stock options $ 18,798         $ 3 18,795      
Issuance of restricted stock award (in shares)           24,000        
Shares issued under employee stock plan (in shares) 104,363         105,000        
Shares issued under employee stock plans $ 2,445           2,445      
Other comprehensive income gain (loss), net of tax (379)             (379)    
Net income 150,631               150,631  
Ending balance (in shares) at Dec. 26, 2019     101,457,858 0 0 101,458,000        
Ending balance at Dec. 26, 2019 764,336         $ 101 370,413 (193) 394,015  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense $ 16,115           16,115      
Exercise of stock options (in shares) 2,485,427         2,485,000        
Exercise of stock options $ 19,254         $ 2 19,252      
Issuance of restricted stock award (in shares)           369,000        
Issuance of restricted stock awards $ 1         $ 1        
Shares issued under employee stock plan (in shares) 56,389         56,000        
Shares issued under employee stock plans $ 2,344           2,344      
Other comprehensive income gain (loss), net of tax 357             357    
Net income 194,981               194,981  
Ending balance (in shares) at Dec. 31, 2020     104,368,212 0 0 104,368,000        
Ending balance at Dec. 31, 2020 $ 997,388         $ 104 $ 408,124 $ 164 $ 588,996